Studies on the Synthetic Methodology of Head to Tail Cyclization of Linear Peptides

Summary Our recent studies on the synthetic methodology of head to tail cyclization of linear peptides are summarized in this paper. Ten cyclopeptides including six cyclopentapeptides as candidates of LHRH antagonists, two cyclopentapeptides, and two cycloheptapeptides which were isolated from Chinese medicinal herbs were synthesized using an organic phosphorus reagent, DEPBT, and were selected as model peptides for studying the factors that influence the cyclization yields. Our results show that the coupling reagent choice and linear peptide sequence are the two most important considerations that determine the success or failure for a cyclization reaction. Effects of different metal ions on the cyclization were also studied. The results suggest that Na⁺ is suitable for promoting the cyclization of linear pentapeptides while bigger Cs⁺ is better for promotion of the ring closure of linear heptapeptides. Application of Pac ester in thioester method for synthesis of cyclopeptides was studied. N-protected amino acid and peptide thioesters with Pac group were readily purified in each step of synthesis. The Pac group was easy to remove with zinc powder in acetic acid and its flexibility allows elongatation of the peptide chain from either N-or C-terminal.     

Designing cyclopentapeptide inhibitor as potential antiviral drug for dengue virus ns5 methyltransferase

NS5 methyltransferase (Mtase) has a crucial role in the replication of dengue virus. There are two active sites on NS5 Mtase i.e., SAM and RNA-cap binding sites. Inhibition of the NS5 Mtase activity is expected to prevent the propagation of dengue virus. This study was conducted to design cyclic peptide ligands as enzyme inhibitors of dengue virus NS5 Mtase through computational approach. Cyclopentapeptides were designed as ligand of SAM binding site as much as 1635 and 736 cyclopentpeptides were designed as ligand of RNA-cap binding site. Interaction between ligand and NS5 Mtase has been conducted on the Docking simulation. The result shows that cyclopentapeptide CTWYC was the best peptide candidate on SAM binding site, with estimated free binding energy -30.72 kca/mol. Cyclopentapeptide CYEFC was the best peptide on RNA-cap binding site with estimated free binding energy -22.89 kcal/mol. Both peptides did not have tendency toward toxicity properties. So it is expected that both CTWYC and CYEFC ligands could be used as a potential antiviral drug candidates, which can inhibit the SAM and RNA-cap binding sites of dengue virus NS5 Mtase.